(Date:11/4/2009)..., ST. LOUIS and BEIJING, Nov. 4, 2009 /PRNewswir...ounced today that it is opening its first research...ment to forming technology collaborations in the c... Center in Zhongguancun, Beijing, will strengthen ...ons in plant biotechnology and genomics. ,, Th...
(Date:11/3/2009)..., ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstC...remier anatomic pathology and molecular testing se...the pharmaceutical industry, today reported financ...ended September 30, 2009. Results included a 13 p...ter of 2009 as compared to the third quarter of 20...
(Date:11/3/2009)..., WILMINGTON, Del., Nov. 3 Ferti...nception Framework - the 5-step, definitive, and.... Available for immediate download as a free e-boo...rk equips couples with the knowledge, principles, ...oductive health, and increase their chances of con...
(Date:11/3/2009)..., SOUTH SAN FRANCISCO, Calif., Nov. 3 /PRNewswir...daq: PARD ), a biopharmaceutical company focused ...the third quarter ended September 30, 2009, and pr...d quarter, we reached the 320th event target in ou... picoplatin for the treatment of small cell lung c...
Breaking Biology Technology:Monsanto Opens First Biotechnology Research Center in China 2Monsanto Opens First Biotechnology Research Center in China 3Clarient Reports 2009 Third Quarter; Nine Month Results 2Clarient Reports 2009 Third Quarter; Nine Month Results 3Clarient Reports 2009 Third Quarter; Nine Month Results 4Clarient Reports 2009 Third Quarter; Nine Month Results 5Clarient Reports 2009 Third Quarter; Nine Month Results 6Clarient Reports 2009 Third Quarter; Nine Month Results 7Clarient Reports 2009 Third Quarter; Nine Month Results 8Clarient Reports 2009 Third Quarter; Nine Month Results 9Clarient Reports 2009 Third Quarter; Nine Month Results 10Clarient Reports 2009 Third Quarter; Nine Month Results 11Fertili-Plus Introduces 5-Step Conception Framework 2Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 7...Aug. 29 Pharmion Corporation,(Nasdaq: PHRM ) tod...ation,(FDA) has granted Fast Track designation for...tic Syndromes (MDS). Fast Track programs are desi...e review of new drugs that are intended to treat s...onstrate the potential to address,unmet medical ne...
...29 /PRNewswire-FirstCall/ - Angiotech Pharmaceutic...ialty pharmaceutical and,medical device company, t...tration (FDA) has given clearance to begin marketi... The Hemo-Stream catheter, developed by Rex Medica...specifically designed for over-the-wire,delivery. ...
...& Webcast Today at 10:00 CET, AMSTERDAM, August 2...), a leader in the field of human gene therapy,tod... 2007. Highlights - Successful IPO, raising gros...valents of EUR 56.3 million at June 30, 2007 - Ex...CIMA, one of,Europe,s leading gene therapy centers...
Other Biology Technology:Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 2Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 3Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 4Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 5Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 6Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance 2Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance 3Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance 4Amsterdam Molecular Therapeutics Reports Half Year Results 2007 2Amsterdam Molecular Therapeutics Reports Half Year Results 2007 3Amsterdam Molecular Therapeutics Reports Half Year Results 2007 4Amsterdam Molecular Therapeutics Reports Half Year Results 2007 5Amsterdam Molecular Therapeutics Reports Half Year Results 2007 6Amsterdam Molecular Therapeutics Reports Half Year Results 2007 7...an State University doctoral student Jennifer Smit...e together and more importantly hunt for their f... journal Animal Behaviour , Smith, a student in M...ed hyenas know the value of living together in lar...venturing on their own now and then to hunt for fo...
...ciety for Microbiology (ASM) BD Award for Research...ephen C. Edberg, Professor, Department of Laborato... School of Medicine, and Director, Clinical Microb...red by BD Diagnostic Systems, this award recognize...hments that form the foundation for important appl...
...ciety for Microbiology (ASM) TREK Diagnostic ABMM/...to Vickie S. Baselski, Professor, University of Te...e of the ABMM or the ABMLI for outstanding contrib... microbiologists and/or immunologists. , Dr. Base...ry reimbursement and coding of diagnostic tests. S...
Other Biology News:Spotted hyenas can increase survival rates by hunting alone 2American Society for Microbiology honors Stephen C. Edberg 2American Society for Microbiology honors Vickie S. Baselski 2...oarrays Using the New FAST(tm) Frame Multi-Slide P...ned to hold four, 16-pad FAST Slides and the corre...plate footprint for high throughput processing of ...ndards recommended by the Society of Biomolecular ...
...ns Package Superior Protein Detection and Quantit...Proteomic Imaging System is a highly sensitive ima...ience research applications. ProXPRESS 2D provides... dyes in the UV and VIS spectrum range with its CC...
a-Hyb Hybridization Station from Miltenyi Biotec
Northern BoundTM Human Alzheimer's Total RNA Blot from Sigma-Aldrich
Biology Products: